Megan graduated from Yale University with a BS in molecular and cellular biology and from the Wharton School of Business with an MBA in Healthcare Management & Corporate Strategy.
She has had a 25-year career in the biopharma industry across 3 companies. Her roles have included both corporate functions (business development, finance, and strategy), with a focus on M&A, and commercial functions (marketing, market access, and sales leadership).
Most recently, Megan has held strategy and operations positions in European and worldwide functions. Her experience includes larger team leadership across multiple geographies/cultures. She thrives in areas of disruptive transformation and excels at change leadership and consortium-building for innovation.
Contact Megan at her LinkedIn profile.